Myopic Chorioretinal Atrophy
📧 Sign up to get email alerts when something new happens for Myopic Chorioretinal Atrophy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-08-15Clinical Trial Update: Clinical Study of PAL-222 Targeting Patients With Myopic Chorioretinal Atrophy (PAMyCA) [NA]
A clinical study of PAL-222 for myopic chorioretinal atrophy is ongoing, with status listed as ACTIVE_NOT_RECRUITING.